OVERLAND PARK, Kan., 16 Jan 2025: Parnell, a leader in high-quality pet care products, has introduced PropofolVet Multidose, the first generic injectable emulsion of propofol specifically designed for dogs. This innovative anesthetic solution promises to enhance operational efficiency in veterinary practices while ensuring top-notch patient care.
Key Points
1.
First generic propofol injectable emulsion for canine anesthesia
2.
Convenient 28-day shelf life without refrigeration
3.
Cost-effective alternative to existing anesthetic solutions
4.
Supports flexible anesthesia protocols for veterinarians
Revolutionizing Veterinary Anesthesia
PropofolVet Multidose provides veterinarians with a versatile tool for both inducing and maintaining general anesthesia in dogs. It supports intermittent bolus injections for short procedures and can also be effectively combined with inhalant anesthetics for maintenance. This flexibility allows veterinary professionals to tailor their anesthesia protocols to meet diverse patient needs.
"We understand the intricate challenges that veterinary professionals encounter with anesthesia," stated Chelsie Estey, MSc, DVM, DACVIM (Neurology) and Vice President of U.S. Pet Care at Parnell. "PropofolVet Multidose significantly enhances our existing sedation and anesthesia offerings, ensuring that veterinary teams can access and confidently use our products."
Key Features of PropofolVet Multidose
Cost-Effective Quality: Serves as a reliable and affordable alternative to PropoFlo 28.
First Generic Option: Marks the introduction of the first generic propofol injectable emulsion for dogs in the market.
Extended Usability: Offers a convenient 28-day in-use shelf life.
No Refrigeration Needed: Simplifies storage and handling in veterinary settings.
Consistent Performance: Ensures reliable and high-quality induction for anesthesia procedures.
"As the first generic propofol available in the veterinary anesthesia and sedation sector, PropofolVet Multidose meets a vital market demand by delivering a high-quality, budget-friendly solution that improves practice efficiency without sacrificing care standards," remarked Pablo Lamberto, DVM and Senior Vice President and President of U.S. Operations for Parnell.
Streamlining Veterinary Practice Operations
The launch of PropofolVet Multidose complements Parnell's extensive portfolio of anesthesia and sedation products, which includes Dexmedetomidine Hydrochloride Injection and CONTRASED (atipamezole hydrochloride). This comprehensive suite helps simplify inventory management while providing veterinary practices with a dependable solution for all their sedation and anesthesia requirements.
Veterinary professionals interested in learning more about PropofolVet Multidose can reach out to their distributor representative or visit www.parnell.com for additional information.
